» Articles » PMID: 26542405

[Antimicrobial Prosthesis Coatings]

Overview
Journal Orthopade
Specialty Orthopedics
Date 2015 Nov 7
PMID 26542405
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Antimicrobial coatings have a great potential in the treatment and prevention of periprosthetic joint infection.

Objective: To present established and novel concepts of antimicrobial coatings.

Methods: A literature review and discussion of published concepts in basic research, pre-clinical animal studies, and clinical practice were carried out.

Results: To date there has been a wide range of technical solutions (anti-adhesive surfaces, bioactive surfaces with antimicrobial effects, surfaces releasing antimicrobial substances, nanostructures, bioactive surfaces affecting biofilm development) demonstrating a high potential in pre-clinical studies. Only a few with the bactericidal activity of silver ions have been prepared for the market. Conclusive results with regard to biocompatibility and toxicity are lacking.

Discussion: Despite the great potential of antimicrobial coatings, no conclusive decisions can be made because of the limited data and the lack of evidence of their clinical efficacy on the basis of prospective controlled clinical studies. In addition to their unlimited biocompatibility, innovative concepts have to be feasible in everyday clinical routine.

Citing Articles

[The significance of biofilm for the treatment of infections in orthopedic surgery : 2017 Update].

Scheuermann-Poley C, Wagner C, Hoffmann J, Moter A, Willy C Unfallchirurg. 2017; 120(6):461-471.

PMID: 28540567 DOI: 10.1007/s00113-017-0361-y.

References
1.
van de Belt H, Neut D, Uges D, Schenk W, van Horn J, van der Mei H . Surface roughness, porosity and wettability of gentamicin-loaded bone cements and their antibiotic release. Biomaterials. 2000; 21(19):1981-7. DOI: 10.1016/s0142-9612(00)00082-x. View

2.
Darouiche R, Mansouri M, Gawande P, Madhyastha S . Antimicrobial and antibiofilm efficacy of triclosan and DispersinB combination. J Antimicrob Chemother. 2009; 64(1):88-93. DOI: 10.1093/jac/dkp158. View

3.
Wimmer M, Vavken P, Pagenstert G, Valderrabano V, Randau T, Wirtz D . Spacer usage in prosthetic joint infections does not influence infect resolution: retrospective analysis of 120 joints with two-stage exchange.Re: Clinical outcome and microbiological findings using antibiotic-loaded spacers in two-stage revision of.... J Infect. 2013; 67(1):82-4. DOI: 10.1016/j.jinf.2013.02.001. View

4.
Huang Z, Zheng X, Yan D, Yin G, Liao X, Kang Y . Toxicological effect of ZnO nanoparticles based on bacteria. Langmuir. 2008; 24(8):4140-4. DOI: 10.1021/la7035949. View

5.
Tenke P, Koves B, Johansen T . An update on prevention and treatment of catheter-associated urinary tract infections. Curr Opin Infect Dis. 2013; 27(1):102-7. DOI: 10.1097/QCO.0000000000000031. View